1. Home
  2. LOBO vs GLYC Comparison

LOBO vs GLYC Comparison

Compare LOBO & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOBO
  • GLYC
  • Stock Information
  • Founded
  • LOBO 2014
  • GLYC 2003
  • Country
  • LOBO China
  • GLYC United States
  • Employees
  • LOBO N/A
  • GLYC N/A
  • Industry
  • LOBO
  • GLYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • LOBO
  • GLYC Health Care
  • Exchange
  • LOBO NYSE
  • GLYC Nasdaq
  • Market Cap
  • LOBO 13.6M
  • GLYC 14.2M
  • IPO Year
  • LOBO 2024
  • GLYC 2014
  • Fundamental
  • Price
  • LOBO $0.66
  • GLYC $0.26
  • Analyst Decision
  • LOBO
  • GLYC Hold
  • Analyst Count
  • LOBO 0
  • GLYC 3
  • Target Price
  • LOBO N/A
  • GLYC N/A
  • AVG Volume (30 Days)
  • LOBO 105.3K
  • GLYC 498.0K
  • Earning Date
  • LOBO 05-06-2025
  • GLYC 05-08-2025
  • Dividend Yield
  • LOBO N/A
  • GLYC N/A
  • EPS Growth
  • LOBO N/A
  • GLYC N/A
  • EPS
  • LOBO 0.00
  • GLYC N/A
  • Revenue
  • LOBO $19,469,766.00
  • GLYC N/A
  • Revenue This Year
  • LOBO $72.16
  • GLYC N/A
  • Revenue Next Year
  • LOBO $41.04
  • GLYC N/A
  • P/E Ratio
  • LOBO $612.06
  • GLYC N/A
  • Revenue Growth
  • LOBO N/A
  • GLYC N/A
  • 52 Week Low
  • LOBO $0.46
  • GLYC $0.14
  • 52 Week High
  • LOBO $3.52
  • GLYC $1.93
  • Technical
  • Relative Strength Index (RSI)
  • LOBO N/A
  • GLYC 64.07
  • Support Level
  • LOBO N/A
  • GLYC $0.21
  • Resistance Level
  • LOBO N/A
  • GLYC $0.27
  • Average True Range (ATR)
  • LOBO 0.00
  • GLYC 0.02
  • MACD
  • LOBO 0.00
  • GLYC 0.01
  • Stochastic Oscillator
  • LOBO 0.00
  • GLYC 86.67

About LOBO LOBO EV TECHNOLOGIES LTD

Lobo EV Technologies Ltd is an electric vehicle manufacturer and seller company. It designs, develops, manufactures, and sells e-bicycles, e-mopeds, e-tricycles, and electric off-highway four-wheeled shuttles such as golf carts and mobility scooters for the elderly and disabled persons, also provides automobile information and entertainment software development and design services to customers. The company operates in two operating segments: Electric vehicles and accessories sales which generates key revenue, and software royalties and development and design services. It generates all of its revenue within the People's Republic of China.

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Share on Social Networks: